117 related articles for article (PubMed ID: 1381610)
41. Effects of nitroblue tetrazolium and vitamin E on platelet ultrastructure, aggregation, and secretion.
White JG; Rao GH; Gerrard JM
Am J Pathol; 1977 Aug; 88(2):387-402. PubMed ID: 879276
[TBL] [Abstract][Full Text] [Related]
42. Modification of platelet functions by monobromobimane, a fluorescent thiol group label.
Zucker MB; Mauss EA
Thromb Haemost; 1986 Apr; 55(2):228-34. PubMed ID: 3012818
[TBL] [Abstract][Full Text] [Related]
43. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
Xu X; Ye X; Xia W; Liu J; Ding H; Deng J; Chen Y; Shao Y; Wang J; Fu Y; Santoso S
Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019
[TBL] [Abstract][Full Text] [Related]
44. Platelet aggregation responses vary over a period of time in healthy controls.
Refaai MA; Frenkel E; Sarode R
Platelets; 2010; 21(6):460-3. PubMed ID: 20536288
[TBL] [Abstract][Full Text] [Related]
45. [Platelet aggregation induced by adenosine diphosphate, collagen and adrenaline in human platelet subpopulations].
Nubile G; Di Gregorio M; Ridolfi D; D'Alonzo L; Izzi L
Quad Sclavo Diagn; 1987 Sep; 23(3):331-40. PubMed ID: 3140287
[TBL] [Abstract][Full Text] [Related]
46. Characterization of the aggregation responses of camel platelets.
Al Ghumlas AK; Gader AG
Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
[TBL] [Abstract][Full Text] [Related]
47. Platelet dysfunction associated with immune-mediated thrombocytopenia in dogs.
Kristensen AT; Weiss DJ; Klausner JS
J Vet Intern Med; 1994; 8(5):323-7. PubMed ID: 7837107
[TBL] [Abstract][Full Text] [Related]
48. A resolution of reported discrepancies in the characteristics of platelet glycoproteins IV (GPIV) and IIIb (GPIIIb).
Yamamoto N; de Romeuf C; Tandon NN; Jamieson GA
Thromb Haemost; 1990 Feb; 63(1):97-102. PubMed ID: 1692640
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of platelet glycoprotein IV (CD36).
Tandon NN; Lipsky RH; Burgess WH; Jamieson GA
J Biol Chem; 1989 May; 264(13):7570-5. PubMed ID: 2468669
[TBL] [Abstract][Full Text] [Related]
50. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement.
Kobune K; Inoue M; Morikawa M; Tsuboi M; Takanami Y; Iwane Y; Kudo T
Res Commun Chem Pathol Pharmacol; 1991 Nov; 74(2):153-65. PubMed ID: 1811279
[TBL] [Abstract][Full Text] [Related]
51. Identification of platelet membrane thrombospondin binding molecules using an anti-thrombospondin antibody.
Kieffer N; Nurden AT; Hasitz M; Titeux M; Breton-Gorius J
Biochim Biophys Acta; 1988 Dec; 967(3):408-15. PubMed ID: 2461742
[TBL] [Abstract][Full Text] [Related]
52. A novel role for CD36 in VLDL-enhanced platelet activation.
Englyst NA; Taube JM; Aitman TJ; Baglin TP; Byrne CD
Diabetes; 2003 May; 52(5):1248-55. PubMed ID: 12716760
[TBL] [Abstract][Full Text] [Related]
53. Malondialdehyde formation as an indicator of prostaglandin production by human platelets.
Smith JB; Ingerman CM; Silver MJ
J Lab Clin Med; 1976 Jul; 88(1):167-72. PubMed ID: 932533
[TBL] [Abstract][Full Text] [Related]
54. The effect of ex vivo anticoagulants on whole blood platelet aggregation.
Kalb ML; Potura L; Scharbert G; Kozek-Langenecker SA
Platelets; 2009 Feb; 20(1):7-11. PubMed ID: 19172515
[TBL] [Abstract][Full Text] [Related]
55. Analysis of the human CD36 leucocyte differentiation antigen by means of the monoclonal antibody NL07.
Alessio M; Ghigo D; Garbarino G; Geuna M; Malavasi F
Cell Immunol; 1991 Oct; 137(2):487-500. PubMed ID: 1716523
[TBL] [Abstract][Full Text] [Related]
56. Interaction of platelet factor 4 with human platelets.
Capitanio AM; Niewiarowski S; Rucinski B; Tuszynski GP; Cierniewski CS; Hershock D; Kornecki E
Biochim Biophys Acta; 1985 Apr; 839(2):161-73. PubMed ID: 4039192
[TBL] [Abstract][Full Text] [Related]
57. Superoxide anion and hydroxyl radical release by collagen-induced platelet aggregation--role of arachidonic acid metabolism.
Caccese D; Praticò D; Ghiselli A; Natoli S; Pignatelli P; Sanguigni V; Iuliano L; Violi F
Thromb Haemost; 2000 Mar; 83(3):485-90. PubMed ID: 10744158
[TBL] [Abstract][Full Text] [Related]
58. Butyltin compounds in vitro inhibition of human platelet epinephrine-induced aggregation and blockade of epinephrine binding to platelets.
Yanagisawa H; Wada O
Ind Health; 1985; 23(4):255-68. PubMed ID: 3938784
[No Abstract] [Full Text] [Related]
59. Binding of recombinant apolipoprotein(a) to human platelets and effect on platelet aggregation.
Martínez C; Rivera J; Loyau S; Corral J; González-Conejero R; Lozano ML; Vicente V; Anglés-Cano E
Thromb Haemost; 2001 Apr; 85(4):686-93. PubMed ID: 11341506
[TBL] [Abstract][Full Text] [Related]
60. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
Ts'ao C
Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
